SCM
GRCE

Stonepine Capital Management’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Stonepine Capital Management’s Portfolio GRCE Stock Details GRCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$869K Sell
292,500
-2,050
-0.7% -$6.09K 0.85% 31
2025
Q1 		$666K Buy
+294,550
New +$666K 0.65% 31